Covid: United Arab Emirates register Chinese vaccine Sinopharm, 86% effective – Health



[ad_1]

The United Arab Emirates has registered China’s experimental Sinopharm vaccine, which has been found to be 86% effective against Covid-19, according to an interim analysis of phase 3 trials that began in July. The vaccine was developed by the Beijing Institute of Biological Products, a unit of the Sinopharm China National Biotec Group. In September, the Gulf country approved the serum for emergency use for some specific categories.
The analysis, the Health Ministry said, also showed “a 99% seroconversion rate and 100% efficacy in preventing moderate and severe cases of the disease.”

Meanwhile, the national drug control authority (MHRA) today recommended not vaccinating against Covid those with a history of “significant” allergic reactions. The indication came after two of the hundreds of people who were administered the Pfizer / Biontech vaccine in the United Kingdom – the first country to give the green light to public distribution yesterday, following the green light given in recent days by the same Mhra– had allergic reactions.

REPRODUCTION RESERVED © Copyright ANSA